PFU - plaque-forming unit
Showing 1 - 25 of 9,967
Cytomegalovirus Infections, HIV, Vaccine Trial in United States (CMV-MVA Triplex, Placebo)
Recruiting
- Cytomegalovirus Infections
- +2 more
- CMV-MVA Triplex
- Placebo
-
Birmingham, Alabama
- +11 more
Jun 20, 2022
Colorectal Cancer, Colorectal Carcinoma, Colorectal Adenocarcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Pexa-Vec)
Active, not recruiting
- Colorectal Cancer
- +4 more
- Durvalumab
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Bacterial Disease Carrier, Cystic Fibrosis Trial in United States (Placebo, WRAIR_PAM-CF1)
Recruiting
- Bacterial Disease Carrier
- Cystic Fibrosis
- Placebo
- WRAIR_PAM-CF1
-
La Jolla, California
- +14 more
Aug 11, 2022
Melanoma Patients Treated With IMLYGIC® to Characterize Risk of
Recruiting
- Melanoma
- Herpetic Infection
-
Jefferson City, Missouri
- +16 more
Apr 11, 2022
Covid19 Trial in United States (CVXGA1 low dose, CVXGA1 high dose)
Recruiting
- Covid19
- CVXGA1 low dose
- CVXGA1 high dose
-
Bardstown, Kentucky
- +3 more
Aug 16, 2022
Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (VAC?6 vaccine - ?nce at a dose of 106 PFU, VAC?6 vaccine - once at a dose of
Completed
- Smallpox
- +3 more
- VAC∆6 vaccine - оnce at a dose of 10⁶ PFU
- +3 more
-
Novosibirsk, Koltsovo, Novosibirsk Region, Russian FederationFederal State Budgetary Healthcare Institution - Medical and San
Feb 28, 2023
Yellow Fever Vaccination Reaction Trial in Frederick (Yellow Fever Vaccine)
Active, not recruiting
- Yellow Fever Vaccination Reaction
- Yellow Fever Vaccine
-
Frederick, MarylandUnited States Army Medical Research Institute of Infectious Dise
May 17, 2022
Respiratory Syncytial Virus Infections Trial in Cincinnati, North Charleston (CPI-RSV-F Vaccine (BLB-201))
Completed
- Respiratory Syncytial Virus Infections
- CPI-RSV-F Vaccine (BLB-201)
-
Cincinnati, Ohio
- +1 more
Dec 5, 2022
Respiratory Syncytial Virus Infections Trial in Baltimore (rRSV A/Maryland/001/11)
Suspended
- Respiratory Syncytial Virus Infections
- rRSV A/Maryland/001/11
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health
Feb 8, 2022
Bacterial Growth, Novel Influenza A (H1N1) Trial in Jilin (A novel electrolyzed water spray reduces numbers of bacteria E-coli
Recruiting
- Bacterial Growth
- Novel Influenza A (H1N1)
- A novel electrolyzed water spray reduces numbers of bacteria E-coli and an attenuated human flu virus on human hands
-
Jilin, Changchun, ChinaChangchun Jiahe Surgery Hospital
Apr 1, 2023
Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic
Not yet recruiting
- Chronic Lymphocytic Leukemia
- COVID-19 Infection
- Biospecimen Collection
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 3, 2023
Respiratory Syncytial Virus (RSV) Trial in United States (RSV ?NS2/?1313/I1314L Vaccine, RSV 6120/?NS2/1030s Vaccine, RSV 276
Recruiting
- Respiratory Syncytial Virus (RSV)
- RSV ΔNS2/Δ1313/I1314L Vaccine
- +3 more
-
La Jolla, California
- +17 more
Dec 14, 2021
Smallpox, Monkeypox, Cowpox Trial in Koltsovo, Novosibirsk (VAC?6 vaccine (107 PFU), VAC?6 vaccine (106 PFU), Live Smallpox
Completed
- Smallpox
- +3 more
- VAC∆6 vaccine (10⁷ PFU)
- +3 more
-
Koltsovo, Novosibirsk Region, Russian Federation
- +1 more
Apr 25, 2023
HIV-1-infection Trial in Kenya, Uganda, Zambia (Vaccine, Placebo)
Active, not recruiting
- HIV-1-infection
- Vaccine
- Placebo
-
Kilifi, Kenya
- +3 more
Jun 21, 2022
Infectious Disease, Yellow Fever, Japanese Encephalitis Trial (Stamaril, Imojev, Ixiaro)
Not yet recruiting
- Infectious Disease
- +3 more
- Stamaril
- +2 more
- (no location specified)
Oct 3, 2022
Human Immunodeficiency Virus Trial in Boston (Ad26.Mos4.HIV, MVA-Mosaic, Clade C gp140 + Mosaic gp140)
Completed
- Human Immunodeficiency Virus
- Ad26.Mos4.HIV
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Feb 7, 2022
Periodontal Diseases, Chronic Periodontitis, Microbial Colonization Trial in Bogotá (Mouthwash, Chlorhexidine)
Completed
- Periodontal Diseases
- +2 more
- Mouthwash
- Chlorhexidine
-
Bogotá, ColombiaUniversidad El Bosque
Jul 17, 2023
Fluoride Adverse Reaction Trial (AVIVA-PURE-CocoPull-Organic-made in USA)
Not yet recruiting
- Fluoride Adverse Reaction
- AVIVA-PURE-CocoPull-Organic-made in USA
- (no location specified)
Apr 7, 2023
Coronavirus Disease (COVID-19) Trial in United States (V590, Placebo)
Terminated
- Coronavirus Disease (COVID-19)
- V590
- Placebo
-
Tempe, Arizona
- +6 more
Dec 22, 2021
Dengue Trial in Syracuse (Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC), Dengue virus 3 Live Virus Human Challenge
Not yet recruiting
- Dengue
- Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC)
- Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC)
-
Syracuse, New YorkState University of New York, Upstate Medical University (SUNY-U
Jul 28, 2023
Evaluations, Diagnostic Self, Antimicrobial, Orthodontic Appliance Complication Trial in Baghdad (Zinc oxide nanoparticle coated
Completed
- Evaluations, Diagnostic Self
- +6 more
- Zinc oxide nanoparticle coated orthodontic molar tubes (experimental)
- orthodontic molar tubes (control)
-
Baghdad, Bab Al Muadam, IraqUniversity of Baghdad /college of dentistry
Oct 11, 2023
Respiratory Syncytial Virus Infections Trial in Cincinnati (PIV5-vectored RSV Vaccine (BLB-201) Low Dose, PIV5-vectored RSV
Not yet recruiting
- Respiratory Syncytial Virus Infections
- PIV5-vectored RSV Vaccine (BLB-201) Low Dose
- +2 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 20, 2022
COVID-19 Infection Trial in Duarte (Placebo Administration, Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1)
Recruiting
- COVID-19 Infection
- Placebo Administration
- Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Dec 15, 2021
Breast Tumors, Tumor Metastasis Trial in Boston, Canton (CodaLytic)
Not yet recruiting
- Breast Neoplasms
- Neoplasm Metastasis
- CodaLytic
-
Boston, Massachusetts
- +1 more
Oct 28, 2022
Diabetic Foot Infection Trial (TP-102, Placebo)
Not yet recruiting
- Diabetic Foot Infection
- TP-102
- Placebo
- (no location specified)
Jul 6, 2023